© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 09, 2021
Patients who are treated with B cell depletion therapies show that their B cell count at time of vaccination can impact their COVID-19 antibody response.
An assessment of a rheumatic disease cohort shows Spike protein antibody response is significantly decreased in vaccinated patients, and may vary by treatment.
Lower health literacy has been found to be associated with worsened health outcomes for patients with systemic lupus erythematosus (SLE).
November 08, 2021
Fetal deaths associated with the rheumatic disease have been on the decline, but increased risks persist nonetheless.
Alopecia and nausea risk may be more easily identified in patients initiating methotrexate for rheumatoid arthritis.
A study presented at ACR 2021 found that CBD had no significant effect on pain intensity in patients with hand osteoarthritis or psoriatic arthritis.
An assessment of data from the DISCOVER and VOYAGE trials show the IL-23 inhibitor provides similar safety profiles in patients with either psoriatic disease.
Interim data from a post-marketing analysis suggest a boxed label warning for the drug in 2019 may have limited high-risk patients taking the biologic therapy.
A cross-sectional analysis suggests patients with worse social risk scores are significantly more likely to be impacted by juvenile idiopathic arthritis.
November 07, 2021
This study shows that many patients with rheumatoid arthritis can use a dose lower than 1000mg and still see results.
Patients With Vitiligo Report Varied Severe Symptoms Based on Skin Tone
Ruxolitinib Beneficial Across Demographics of Patients with Vitiligo
Promising Data from InPedILD Phase 3 Trial Revealed at ERS Congress 2022